Anna Ratka, Ph.D., Pharm.D., RPh, CPE, is a Professor and Chair of the Department
of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Dr. Ratka graduated with
M.S. in pharmacy (1981) and Ph.D. in pharmacology (1985) from Poznan University of
Medical Sciences, Poland, and with Pharm.D. from Idaho State University (2000). She
completed two post-doctoral fellowships, in neuropharmacology at Rudolf Magnus Institute
for Pharmacology at the University of Utrecht, the Netherlands (1985-1988), and in
neuroendocrinology at the University of Florida in the Department of Pharmacodynamics
(1988-1991). In 1992, she became a faculty member at the College of Pharmacy at Idaho
State University (ISU). While at ISU, she completed sabbatical training on cancer
pain management at Huntsman Cancer Institute at the University of Utah. In 2003, she
joined the Department of Pharmacology and Neuroscience at University of North Texas
Health Science Center and served as a founding Director of Clinical Research at the
Institute for Aging and Alzheimer’s Disease Research. In 2006, she joined Texas A&M
Health Science Center as a founding chair of the Department of Pharmaceutical Sciences
and made contributions to development and accreditation of Irma Lerma Rangel College
of Pharmacy. In 2013, Dr. Ratka came to Chicago State University College of Pharmacy
as chair of the Department of Pharmaceutical Sciences. Dr. Ratka is a Certified Pain
Educator. She is a board-certified pharmacist with experience in community and hospital
pharmacy practice. Dr. Ratka is a graduate from the American Association of Colleges
of Pharmacy Academic Leadership Fellows Program. As a pharmacy faculty, Dr. Ratka
has taught and mentored pharmacy professional students and graduate students, conducted
research/scholarship, and has been engaged in service to the community and national
Dr. Ratka’s teaching expertise is in pharmacology, pain pharmacotherapy and pain management,
basic pharmacokinetics, and compounding of sterile preparations. She is engaged in
scholarship of teaching. Dr. Ratka research expertise is in neuroscience/neuropharmacology
with special emphasis on pain. In her research she has designed and performed basic
and clinical studies. Her current research focus is on the effects of oxidative damage,
neuronal degeneration and aging on opioid receptors and pain-relieving effects of
opioids. Dr. Ratka has authored about 100 peer-reviewed papers, chapters, and presentations,
is a peer-reviewer for several scientific journals and funding agencies, and serves
on editorial boards. She received awards for teaching and research from her students
Currently, Dr. Ratka is a member of the American Association of Colleges of Pharmacy
(AACP), American Pharmacists Association (APhA), American Pain Society (APS), American
Society of Pain Educators (ASPE), and pharmacy honor societies Phi Delta Chi Pharmacy
Fraternity, Rho Chi Honor Society, and Phi Lambda Sigma Pharmacy Leadership Society.
At the AACP, she has held leadership positions at the Global Pharmacy Education Special
Interest Group, and is a member of the faculty Affairs Committee at the Council of
Faculties. She serves as the on-site team evaluator for the Accreditation Council
for Pharmacy Education.
Ehab A. Abourashed, M.S., Ph.D., is an Associate Professor of Pharmaceutical Sciences
at Chicago State University College of Pharmacy (CSU-COP) and is a graduate of the
Faculty of Pharmacy, Cairo University, Egypt. He has a Master's Degree in Organic
Chemistry from the University of Tennessee, and a Ph.D. in Pharmacognosy from the
University of Mississippi. Before joining CSU, Dr. Abourashed was a Lecturing Postdoctoral
Research Associate at the University of Mississippi School of Pharmacy; a Senior Research
Scientist at GlaxoSmithKline, New Jersey; Associate Professor of Pharmacognosy at
King Saud University, Riyadh; and Director of Quality Assurance at ElSohly Labs, Inc.
in Mississippi. Dr. Abourashed is also an Adjunct Research Associate Professor at
the University of Mississippi’s National Center for Natural Products Research (NCNPR).
Dr. Abourashed's research interests include isolation, structure elucidation and microbial
transformation of biologically active natural products; phyto/bioanalytical method
development; and phytopharmacology of medicinal plants and herbal dietary supplements.
Dr. Abourashed is currently investigating the psychopharmacology of nutmeg, the biological
activities of milk thistle, and the antitubercular potentiating properties of selected
natural phenolics and sesquiterpenes.
Dr. Abourashed is a member of the American Society of Pharmacognosy, The American
Association of Colleges of Pharmacy, the Rho Chi Pharmacy Honor Society and the Phi
Kappa Phi Honor Society. His name is also included in Who’s Who in the World 2006.
Dr. Abourashed has published more than 30 research papers in peer reviewed journals
and is a regular reviewer for the Journal of Natural Products, Planta Medica, Chromatographia
and many others. He is also the coauthor of the 3rd edition of ‘Leung’s Encyclopedia
of Common Natural Ingredients Used in Food, Drugs, and Cosmetics’. Additional information
Michael Bradaric, PhD, is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).
Dr. Bradaric graduated from Lewis University, Romeoville, IL with a BS in Biology
and a minor in Chemistry in 2004. He obtained his PhD in Pharmacology at Rush University
Medical Center, Chicago, IL in 2011. Prior to CSU, Dr. Bradaric completed a post-doctoral
fellowship at the University of Chicago in the department of Obstetrics and Gynecology.
Dr. Bradaric’s research interests have been in multi-disciplinary fields pertaining
to the study of ovarian cancer. Previous work involved identifying new clinical targets
based on pathological assessment of human tissue, comparative studies using animal
models of ovarian cancer (chicken and mouse), and the use of human ovarian cancer
cells to screen novel drugs for anti-proliferative efficacy. Dr. Bradaric is currently
examining the role of the tumor cytokine signaling network, and the pharmacological
targeting of the cross-talk between cells of the immune system and the developing
tumor. His research achievements in these areas are documented in several peer-reviewed
journal articles in the ovarian cancer literature and in numerous poster presentations.
Cross-institutional studies are geared toward early diagnosis and chemoprevention.
Dr. Bradaric has lectured physiology and pharmacology courses, and has clinical pharmacy
and autopsy experience. Dr. Bradaric is a member of the American Association for Cancer
Research (AACR), the American Society for Pharmacology and Experimental Therapeutics
Michael Danquah, M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his Bachelors
in Chemical Engineering from Kwame Nkrumah University of Science and Technology, Ghana.
Dr. Danquah has a Master’s Degree in Chemical Engineering from the University of Kentucky,
and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health
Dr. Danquah’s research interests include: (i) Design and synthesis of novel biodegradable
polymers for controlled drug and nucleic acid delivery, (ii) Nano based combination
therapy for treating cancer, (iii) Design and construction of novel bipartite shRNA
expressing plasmids for cancer therapy, (iv) Formulation, delivery, in vitro and in
vivo characterization of siRNA and shRNA for treating cancer and (v) Application of
stem cells and biomaterials for tissue regeneration and repair. His research accomplishments
in these areas are documented in published peer-reviewed journal articles. Dr. Danquah
also serves as a regular reviewer for Pharmaceutical Research and Advanced Drug Delivery
Reviews and is a member of the American Association of Colleges of Pharmacy (AACP),
the American Association of Pharmaceutical Scientists (AAPS), and the Controlled Release
at Chicago State University College of Pharmacy (CSU-COP). Prior to joining CSU-COP,
he was an assistant professor of pharmaceutical sciences at Lake Erie College of Osteopathic
Medicine (LECOM), School of Pharmacy. Dr. Do has received awards in recognition of
his teaching, research and service.
Dr. Do received his B.S. from the University of Georgia and Ph.D. in pharmaceutical
sciences (pharmaceutics) from Mercer University, College of Pharmacy & Health Sciences.
His research interests are in the areas of cancer epigenetics, drug delivery systems,
dosage form formulation, microencapsulation technology, and pharmaceutical compounding.
Dr. Do has over 60 publications and presentations. Currently, he serves as a copyeditor
for European Journal of Chemistry, as a member of the Editorial Board for seven (7)
journals and as a reviewer for fourteen (14) scientific journals. Additionally, Dr.
Do has served as an abstract and grant reviewer for several organizations.
In regards to teaching, he has taught pharmaceutics courses, including advanced drug
delivery systems, pharmaceutical dosage forms, pharmaceutical compounding and pharmacokinetics.
Dr. Do is a member of several scientific and professional organizations, including
the American Association of Colleges of Pharmacy (AACP) and the American Association
of Pharmaceutical Scientists (AAPS).
Abir El-Alfy, B. Pharm., M.S., Ph.D., is an Associate Professor of Pharmaceutical
Sciences at Chicago State University College of Pharmacy (CSU-COP) and is a graduate of the
Faculty of Pharmacy, Cairo University, Egypt. She has a Master's Degree in Microbiology
from the University of Mississippi, and a Ph.D. in Pharmacology and Toxicology from
the University of Mississippi. Before joining CSU, Dr. El-Alfy was an Assistant Professor
of Pharmacology, as well as the Director of the Behavioral Neuroscience Core-NPN at
the School of Pharmacy, University of Mississippi.
Dr. El-Alfy's research interest fall in two categories: 1) establishing the molecular
mechanisms underlying the neurotoxicity of acrylamide in both young and adult animal
models and 2) understanding the role of the endocannabinoid system in neuropsychiatric
disorders as depression, anxiety, and posttraumatic disorder. The ultimate goal of
his research is to develop novel drugs that prevent/treat the acrylamide-induced neurotoxicity
as well as develop new therapeutic targets for the treatment of neuropsychiatric disorders.
Dr. El-Alfy has been teaching in Pharmacy Schools for over 10 years. Her teaching
experiences span basic physiology and biochemistry to pharmacology and toxicity, clinical
pharmacology and toxicology, as well as advance graduate courses.
Dr. El-Alfy's is a member of The American Association of Colleges of Pharmacy, The
American Society of Pharmacology and Experimental Therapeutics, the American Society
of Pharmacognosy, the Rho Chi Pharmacy Honor Society, and the Phi Kappa Phi Honor
Society. Dr. El-Alfy has published more than 20 research papers in peer reviewed journals
and is a regular reviewer for the Journal of Diabetes Complications, Planta Medica,
Journal of Advanced Research, and many others. She holds two patents, one on developing
indole compounds as antidepressant medication, and another on developing ptereostilbene
as an anxiolytic. Dr. El-Alfy has presented her research extensively in regional,
national, as well as international meetings. She has won several awads including a
small NIH grant to examine the neurotoxic effects of acrylamide as well as an NIH
COBRE junior investigator grant to examine the mechanism of antidepressant action
Nadeem Fazal, M.D, Ph.D. is an Associate Professor of Pharmaceutical Sciencesat Chicago State University College of Pharmacy (CSU-COP). He received his MD from
King Edward Medical University, Lahore, Pakistan, and PhD in Immunology from The University
of Birmingham, England, United Kingdom. He is a member of American Association for
Immunologists (AAI) and American Society for Microbiology (ASM). He completed his
Post-doctoral training, Fellowship and later served as faculty at Stritch School of
Medicine Loyola University Chicago. Dr. Fazal began his teaching career at the Department
of Microbiology and Immunology, Rawalpindi Medical College, The University of Punjab,
Lahore. He also served as faculty at Chicago State University Department of Biological
Sciences. He has received President’s and Young Scientist Award from Societies of
General Microbiology (SGM), American Society for Microbiology (ASM) and British Society
for Immunology (BSI). He was also a recipient of Rowtham Bequest Award from The University
of Birmingham, England, United Kingdom. His research interests include investigating
mechanisms of cellular immune responses to acute injury/infection and pharmacological
agents modulating such host responses. He has published more than 30 papers in peer-reviewed
scientific journals. Dr. Fazal is a member of numerous scientific and professional
organizations, including, The American Physiological Society (APS), The American Society
of Human Genetics (ASHG), and The American Association of Colleges of Pharmacy (AACP).
Barbara Limburg Mancini, Pharm.D. is Director of Professional Laboratories and Associate
Professor at Chicago State University College of Pharmacy (CSU-COP). She obtained her B.S. in
Pharmacy and Pharm.D. from the University of Illinois at Chicago (UIC), College of
Pharmacy. She was the course coordinator for the Home Infusion Elective course, a
lecturer in Fluids, Electrolytes and Nutrition and a preceptor for the APPE Elective
in Home Infusion Therapy at CSU-COP before joining the Pharmaceutical Sciences Dept.
Dr. Limburg has extensive experience in both Pharmacy Practice and Management in
acute care and alternate sites settings. She holds Board Certification in Nutritional
Support Pharmacy (BCNSP) and has been involved with multidisciplinary Nutritional
Support Services for over 25 years. Dr. Limburg is co-author of the chapter, Beyond
Use Dating of Parenteral Nutrition Formulations in the ASHP publication Extended Stability
for Parenteral Drugs. Dr. Limburg is nationally known in Home Infusion Pharmacy having
lectured at many professional meetings and provided consultation services to numerous
healthcare organizations. She served for many years as a Pharmacist Surveyor for The
Joint Commission (formerly JCAHO) reviewing Home Infusion, Long Term Care, Specialty,
Mail-Order and inpatient pharmacies. Sterile preparation compounding, facilities and
equipment, home health care, process improvement and medication safety have been Dr.
Limburg’s passions throughout her career. She previously taught in the Pharmacy Technician
accredited program at South Suburban College, South Holland, IL, and has precepted
students and residents from many programs.
Dr. Limburg is a member of many professional organizations including the American
Society for Parenteral and Enteral Nutrition, National Home Infusion Association,
American Pharmacists Association, American Society of Health-Systems Pharmacists,
Illinois Council of Health-Systems Pharmacists and Illinois Pharmacists Association.
She is currently serving on the Certification Council of the Pharmacy Technician Certification
Mohammad Newaz MD, Ph.D., FAHA is a Professor of Physiology and Pharmacology in Pharmaceutical
Sciences at Chicago State University College of Pharmacy (CSU-COP). Before joining CSU Dr.
Newaz was Associate Professor / senior Scientist and Head of Hypertension Unit in
the Center for Cardiovascular Diseases, Texas Southern University, Houston, Texas.
Dr. Newaz received his MD from University of Chittagong, Bangladesh (1992) and PhD
from the National University of Malaysia (1998). He has held faculty positions at
the University of Science and Technology Chittagong, Bangladesh, National University
of Malaysia and International Islamic University Malaysia before joining the Center
for Cardiovascular Diseases in 2000. His research focus is primarily on hypertension
and vascular physiology using integrated investigative approach with special emphasis
on understanding molecular events contributing to the pathogenesis of hypertension
and its complications.
Dr. Newaz is a member of many professional societies, including the American Heart
Association, American Physiological Society. He has received numerous honors and awards,
including the Young Investigator Award from High Blood Pressure Council of American
Heart Association, Young Investigator Award from the renal section of The American
Physiological Society, Caroline Tun Suden professional opportunity award from The
American Physiological Society, Young Investigator Award from The International Society
of Hypertension, FASEB MARC fellowship and Grant-in-Aid from American Heart Association.
He has published more than 40 peer reviewed research paper in high impact journals,
book chapters and invited reviews in the field of hypertension and vascular biology.
Dr. Newaz presented his research works extensively at conferences locally and internationally
and was also an invited speaker in several Universities in the US.
Melany P. Puglisi, Ph.D. is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). She received her B.A. in chemistry from Southampton College, now part
of Long Island University, in 1991. Her graduate studies were carried out at University
of Guam where she received her M.S. in Biology in 1995 and the University of Mississippi,
School of Pharmacy where she received her Ph.D. in pharmacognosy. She received grants
from the American Museum of Natural History and the Australian Museum of Natural History
to conduct her research on Guam and the Great Barrier Reef (Lizard Island).
Prior to joining CSU she conducted post-doctoral research at Scripps Institution of
Oceanography at the University of California at San Diego, the Smithsonian Marine
Station at Fort Pierce, and Shannon Point Marine Station at Western Washington University.
Dr. Puglisi’s research interests include marine natural products and chemical ecology
of algae and marine invertebrates. She has participated in numerous research expeditions
in the tropical Atlantic and Pacific including the 2005 NOAA Florida Coast Deep Corals
Dr. Puglisi is a member of several scientific and professional organizations including
the American Association of Colleges of Pharmacy (AACP) and the American Society of
Pharmacognosy. She has served as chair of the Younger Members Committee of the ASP.
Dr. Puglisi has received awards throughout her academic career that not only recognize
her research achievements but also highlight her service to the community.
Jozef Stec, Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).
He received his M.Sc. (with Honors) in Molecular and Pharmaceutical Biotechnology
from Gdansk University of Technology, Poland, and Ph.D. in Synthetic and Mechanistic
Organic Chemistry from the University of Southampton, U.K. Before joining CSU, Dr.
Stec completed postdoctoral training in Synthetic Medicinal Chemistry at the University
of Illinois, Chicago.
Dr. Stec’s research interests are in the field of widely understood synthetic organic
and modern medicinal chemistry. He is especially interested in synthetic innovation
by designing and inventing new reactions, developing them into powerful methodologies
with the aim of their subsequent application to syntheses of biologically active molecules.
Dr. Stec’s research efforts in modern medicinal chemistry are directed towards rational
design and synthesis of inhibitors for various enzymes. This work involves selecting
new molecular targets, structure-based design and subsequent synthesis of small molecules,
which have the potential for therapeutic utility as well as serve as chemical tools
to investigate the biological functions of the molecular targets.
His research achievements in these areas are documented in several peer-reviewed
Dr. Stec is a member of various professional associations including The American Association
of Colleges of Pharmacy (AACP), The American Association of Pharmaceutical Scientists
(AAPS), The American Chemical Society (ACS), The American Association for the Advancement
of Science (AAAS).
During his academic career, Dr. Stec has been teaching for several years the principles
of organic and medicinal chemistry as well as mentoring students at undergraduate
and graduate level.
Daniel W. Pietryla is the Research Laboratory Technician Specialist for Chicago State University College of Pharmacy (CSU-COP). Mr. Pietryla received
his Bachelors Degree in Biology from The University of Chicago (1983). Mr. Pietryla
is the Lab Manager for the Pharmaceutical Sciences Research Facility.
Before joining the College of Pharmacy at CSU in 2012, Mr. Pietryla was a Research
Assistant in the Departments of Biochemistry and Orthopedics at Rush University Medical
Center in Chicago. In a career in basic research spanning 27 years, Mr. Pietryla has
contributed to, as Co-Author, 6 major publications and 29 scientific abstracts in
topics ranging from joint inflammation to intervertebral disc degradation and repair.
Mr. Pietryla brings a diverse technical skills set in biochemical, histological, immunological,
surgical, and clinical protocols and methodologies to the Pharmaceutical Sciences
Research Lab. Additional information at http://www.linkedin.com/pub/dan-pietryla/39/4a8/331.
Tracie Williams is the Office Administrator to the Chair of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Ms. Williams is the central
point of contact for the Department of Pharmaceutical Services, providing administrative
support for the chair and faculty. Ms. Williams joined the department in January 2014.
She brings over 20 years of corporate experience to the department, inclusive of over
5 years of experience as a finance manager in the areas of order processing, invoice
processing, contract audit, and sales support. Her corporate experience also includes
account management, B2B sales, accounts receivable, credit and collections, and customer